Dreem

About:

Dreem is a neurotechnology company composed of sleep pioneers, a team of experts fascinated by science, technology and design.

Website: https://dreem.com/en/about

Twitter/X: dreemrythm

Top Investors: Bpifrance, Xavier Niel, Johnson & Johnson, MAIF Avenir, Laurent Alexandre

Description:

Dreem is a neurotechnology company building consumer technology that stimulates the brain to enhance human potential. The company's product, Dreem is a wearable device that enhances the quality of deep sleep. The device monitors brainwaves, analyzes user's sleep and stimulates the brain with sound in order to extend the amount of deep sleep, improving human performance throughout the day.

Total Funding Amount:

$57M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2014-07-01

Founders:

Hugo Mercier, Quentin Soulet de Brugiere

Number of Employees:

101-250

Last Funding Date:

2018-06-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai